I can’t reliably pull the very latest (e.g., “this week/month”) updates right now, but here are relevant recent-to-midtime scientific updates on hepcidin’s antimicrobial activity and related therapeutic directions.
Recent research themes (what’s been moving)
- Hepcidin-derived peptides as antimicrobials (especially in aquatic models): Reviews and experimental work have focused on hepcidin-derived peptides (often called “hamp” in fish models) and whether specific variants reduce bacterial burden or mortality, sometimes showing that different peptide forms behave differently in vivo.[2][3]
- Mechanistic/optimization work around activity at physiological conditions: Literature emphasizes that antibacterial activity can depend strongly on conditions such as pH and on peptide form (mature peptide vs. fragments/derivatives), which matters for therapeutic translation.[1]
Example of a concrete in vivo result (fish infection model)
A Frontiers review describing experimental models reports that pre-administration of one hepcidin-derived peptide (notably “hamp2”) reduced mortality in an infection model far more than another form (“hamp1”) in that study.[3][2]
If you want, I can narrow it further
Tell me which of these you mean by “latest news,” and I’ll focus the search accordingly:
1) Human clinical trials involving hepcidin/derivatives
2) Antimicrobial peptides/host defense papers (mechanisms, in vitro)
3) Aquaculture use of hepcidin-like peptides (common in the newer AMP literature)
Also, do you want only 2026 items, or “latest 3–12 months”?
Sources
Background/Aims Hepcidin (gene name HAMP), an IL-6-inducible acute phase peptide with antimicrobial properties, is the key negative regulator of iron metabolism. Liver is the primary source of HAMP synthesis, but it is also produced by other tissues such as kidney or heart and is found in body fluids such as urine or cerebrospinal fluid. While the role of hepcidin in biliary system is unknown, a recent study demonstrated that conditional gp130-knockout mice display diminished hepcidin levels...
journals.plos.orgAntimicrobial peptides (AMPs) are involved in the innate immunity of human body to battle microbial pathogens. In addition, human AMPs play also an im…
www.sciencedirect.comThe current treatments applied in aquaculture to limit disease dissemination are mostly based on the use of antibiotics, either as prophylactic or therapeuti...
www.frontiersin.orgHepcidin is a small peptide composed of signal peptide, propeptide, and the bioactive mature peptide from N terminal to C terminal. Mature hepcidin is an antibacterial peptide and iron regulator with eight highly conserved cysteines forming four ...
pmc.ncbi.nlm.nih.govThe increasing frequency of multi-drug resistant microorganisms has driven research into alternative therapeutic strategies. In this respect, natural antimicrobial peptides (AMPs) hold much promise as candidates for the development of novel ...
pmc.ncbi.nlm.nih.govHepcidin is a small peptide composed of signal peptide, propeptide, and the bioactive mature peptide from N terminal to C terminal. Mature hepcidin is an ant...
www.frontiersin.orgThe current treatments applied in aquaculture to limit disease dissemination are mostly based on the use of antibiotics, either as prophylactic or therapeutic agents, with vaccines being available for a limited number of fish species and pathogens. ...
pmc.ncbi.nlm.nih.govThe current treatments applied in aquaculture to limit disease dissemination are mostly based on the use of antibiotics, either as prophylactic or therapeutic agents, with vaccines being available for a limited number of fish species and pathogens. Antimicrobial peptides are considered as promising …
pubmed.ncbi.nlm.nih.gov